Postchemotherapy retroperitoneal lymph node dissection for testis cancer

Michael C. Risk, Richard Foster

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The treatment of patients with metastatic testicular cancer is multimodal. Postchemotherapy retroperitoneal lymph node dissection is a technically demanding procedure that can benefit appropriately selected patients. In this article, we review postchemotherapy retroperitoneal lymph node dissection, including indications, technical updates, and the management and outcomes of patients who undergo surgery. Many aspects continue to evolve, and we review the evidence regarding current controversies in the field.

Original languageEnglish
Pages (from-to)95-106
Number of pages12
JournalExpert Review of Anticancer Therapy
Volume11
Issue number1
DOIs
StatePublished - Jan 2011

Fingerprint

Testicular Neoplasms
Lymph Node Excision
Therapeutics

Keywords

  • nonseminoma
  • retroperitoneal lymph node dissection
  • seminoma
  • testicular cancer

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Oncology

Cite this

Postchemotherapy retroperitoneal lymph node dissection for testis cancer. / Risk, Michael C.; Foster, Richard.

In: Expert Review of Anticancer Therapy, Vol. 11, No. 1, 01.2011, p. 95-106.

Research output: Contribution to journalArticle

@article{8f25a7d408ea41d2ab0648a23d8893e7,
title = "Postchemotherapy retroperitoneal lymph node dissection for testis cancer",
abstract = "The treatment of patients with metastatic testicular cancer is multimodal. Postchemotherapy retroperitoneal lymph node dissection is a technically demanding procedure that can benefit appropriately selected patients. In this article, we review postchemotherapy retroperitoneal lymph node dissection, including indications, technical updates, and the management and outcomes of patients who undergo surgery. Many aspects continue to evolve, and we review the evidence regarding current controversies in the field.",
keywords = "nonseminoma, retroperitoneal lymph node dissection, seminoma, testicular cancer",
author = "Risk, {Michael C.} and Richard Foster",
year = "2011",
month = "1",
doi = "10.1586/era.10.206",
language = "English",
volume = "11",
pages = "95--106",
journal = "Expert Review of Anticancer Therapy",
issn = "1473-7140",
publisher = "Expert Reviews Ltd.",
number = "1",

}

TY - JOUR

T1 - Postchemotherapy retroperitoneal lymph node dissection for testis cancer

AU - Risk, Michael C.

AU - Foster, Richard

PY - 2011/1

Y1 - 2011/1

N2 - The treatment of patients with metastatic testicular cancer is multimodal. Postchemotherapy retroperitoneal lymph node dissection is a technically demanding procedure that can benefit appropriately selected patients. In this article, we review postchemotherapy retroperitoneal lymph node dissection, including indications, technical updates, and the management and outcomes of patients who undergo surgery. Many aspects continue to evolve, and we review the evidence regarding current controversies in the field.

AB - The treatment of patients with metastatic testicular cancer is multimodal. Postchemotherapy retroperitoneal lymph node dissection is a technically demanding procedure that can benefit appropriately selected patients. In this article, we review postchemotherapy retroperitoneal lymph node dissection, including indications, technical updates, and the management and outcomes of patients who undergo surgery. Many aspects continue to evolve, and we review the evidence regarding current controversies in the field.

KW - nonseminoma

KW - retroperitoneal lymph node dissection

KW - seminoma

KW - testicular cancer

UR - http://www.scopus.com/inward/record.url?scp=78650487820&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650487820&partnerID=8YFLogxK

U2 - 10.1586/era.10.206

DO - 10.1586/era.10.206

M3 - Article

C2 - 21166514

AN - SCOPUS:78650487820

VL - 11

SP - 95

EP - 106

JO - Expert Review of Anticancer Therapy

JF - Expert Review of Anticancer Therapy

SN - 1473-7140

IS - 1

ER -